Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
23.45
+0.12 (0.51%)
At close: Mar 23, 2026, 4:00 PM EDT
23.45
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:01 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $844.63 million as of March 23, 2026.
Market Cap
844.63M
Enterprise Value
667.60M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.45
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $844.63M, an increase of 75.51%. That is a compound annual growth rate of 362.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 840.31M | 55.70% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 866.55M |
| SpyGlass Pharma | 866.25M |
| KalVista Pharmaceuticals | 859.29M |
| UroGen Pharma | 857.29M |
| Janux Therapeutics | 855.29M |
| SELLAS Life Sciences Group | 854.81M |
| Sana Biotechnology | 829.96M |
| Adlai Nortye | 819.19M |